The fibril zipper

Credit: COURTESY OF MICHAEL SAWAYA, DAVID EISENBERG/UCLA" /> Credit: COURTESY OF MICHAEL SAWAYA, DAVID EISENBERG/UCLA The paper: R. Nelson et al., "Structure of the cross-β spine of amyloid-like fibrils," Nature, 435:773-8, 2005. (Cited in 119 papers) The finding: In 2005, Howard Hughes Medical Institute Investigator David Eisenberg and his team at the University of California Los Angeles successfully determined the atomic structure o

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The paper:

R. Nelson et al., "Structure of the cross-β spine of amyloid-like fibrils," Nature, 435:773-8, 2005. (Cited in 119 papers)

The finding:

In 2005, Howard Hughes Medical Institute Investigator David Eisenberg and his team at the University of California Los Angeles successfully determined the atomic structure of the protein fibrils formed from sub-pieces of the yeast protein Sup35.

The jargon:

The team was able to image the protein fibril structures from pieces of the protein only seven and then six amino acids in length, each showing their long side chains bound together like Velcro. Eisenberg's team termed this effect the "Dry Steric Zipper," referring to the fact that the structure forms by dehydrating the region between the protein sheets to form an interlocking zone.

The follow up:

In subsequent research, using the original six-amino-acid structure as a template, they have been able to find human sequences likely to form ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Andrea Gawrylewski

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio